Trevi Therapeutics, Inc. (TRVI)
11.12
+0.07
(+0.63%)
USD |
NASDAQ |
Feb 12, 13:15
Trevi Therapeutics EPS Diluted (Quarterly) : -0.0813 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| Arbutus Biopharma Corp. | -0.0404 |
| Bristol Myers Squibb Co. | 0.5326 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.80M |
| Total Expenses (Quarterly) | 11.80M |
| Enterprise Value | 1.223B |
| Earnings Yield | -3.34% |
| Normalized Earnings Yield | -3.339 |